Alison W. Loren

University of Pennsylvania — United States

Medicine · Health Sciences

48h-index13.6kcitations359works5.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(117), Acute Myeloid Leukemia Research(106), Acute Lymphoblastic Leukemia research(49), Chronic Lymphocytic Leukemia Research(34), Lymphoma Diagnosis and Treatment(29)

Publications359 total

Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host Disease
JAMA Dermatology·2026Open Access
Management of Cancer During Pregnancy: ASCO Guideline
Journal of Clinical Oncology·2025· 1 citedOpen Access
IL18-armored CAR T cells in relapsed/refractory B cell acute lymphoblastic leukemia
Blood·2025Open Access
Secondary graft failure after PT-cy: Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution.  Results from the BMT CTN 1801 study.
Blood·2025Open Access
Primary results from Equator, a Phase 3 double-blind, randomized placebo-controlled study evaluating itolizumab in combination with corticosteroids as initial treatment of acute graft-versus-host disease.
Blood·2025· 1 cited
Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes at one year following transplantation: Results from the NMDP sponsored ACCESS study
Blood·2025Open Access
Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study
Blood·2025
Cytotoxic, natural killer-like ex-tissue resident memory T-cells circulate in human chronic graft-versus-host disease at diagnosis
Blood·2025Open Access
Phase II Study of post transplant cyclophosphamide-based graft versus host disease prophylaxis after HLA-mismatched unrelated donor transplantation and reduced intensity conditioning: Results from the NMDP-sponsored access expansion Study
Blood·2025Open Access
Fried's frailty phenotype predicts survival in pts with relapsed/refractory lymphoma or myeloma undergoing chimeric antigen receptor T-cell therapy – a prospective, observational Study
Blood·2025Open Access
Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network·2025· 4 cited
Fertility Preservation in People With Cancer: ASCO Guideline Update
Obstetrical & Gynecological Survey·2025
Vitamin C deficiency in allogeneic hematopoietic cell transplantation recipients in the peri-transplant period
Supportive Care in Cancer·2025
Reply to: Pediatric and Adolescent Considerations for the Revised ASCO Guidelines
Journal of Clinical Oncology·2025
The Art of the Art of Oncology
Journal of Clinical Oncology·2025
Erratum: Fertility Preservation in People With Cancer: ASCO Guideline Update
Journal of Clinical Oncology·2025· 1 cited
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Journal of Clinical Oncology·2025· 11 citedOpen Access
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703
Blood Advances·2025· 4 citedOpen Access
Fertility Preservation in People With Cancer: ASCO Guideline Clinical Insights
JCO Oncology Practice·2025· 3 cited
Erratum: Fertility Preservation in People With Cancer: ASCO Guideline Update
Journal of Clinical Oncology·2025· 2 cited
page 1 of 18Next →

Frequent Co-authors

Edward A. Stadtmauer(15), Selina M. Luger(15), David Porter(14), Noelle V. Frey(13), Elizabeth O. Hexner(12), Hillard M. Lazarus(10), Saar Gill(9), Wael Saber(9), David L. Porter(8), Carl H. June(7), Ran Reshef(7), Bipin N. Savani(7), David A. Jacobsohn(7), Donald E. Tsai(7), Alexander E. Perl(7), Navneet S. Majhail(7), Bruce L. Levine(6), Mary M. Horowitz(6), Sunita D. Nasta(6), John R. Wingard(6)